$MYGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MYRIAD GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MYRIAD GENETICS INC. Get notifications about new insider transactions in MYRIAD GENETICS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Grant | A | 0.00 | 12,848 | 0 | 79,527 | 66.7 K to 79.5 K (+19.27 %) |
| Jun 04 2021 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 12,848 | 0 | 89,527 | 76.7 K to 89.5 K (+16.76 %) |
| Jun 04 2021 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Grant | A | 0.00 | 12,848 | 0 | 83,527 | 70.7 K to 83.5 K (+18.18 %) |
| May 28 2021 | MYGN | MYRIAD GENETICS IN ... | SPIEGELMAN DANIEL K | Director | Sell | D | 0.00 | 15,889 | 0 | 20,562 | 36.5 K to 20.6 K (-43.59 %) |
| May 05 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 19.47 | 19,360 | 376,939 | 68,640 | |
| May 05 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 31.97 | 19,360 | 618,949 | 265,922 | 285.3 K to 265.9 K (-6.79 %) |
| May 05 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 19.47 | 19,360 | 376,939 | 285,282 | 265.9 K to 285.3 K (+7.28 %) |
| Apr 28 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 19.47 | 40,000 | 778,800 | 88,000 | |
| Apr 28 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 31.47 | 40,000 | 1,258,800 | 265,922 | 305.9 K to 265.9 K (-13.08 %) |
| Apr 28 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 19.47 | 40,000 | 778,800 | 305,922 | 265.9 K to 305.9 K (+15.04 %) |
| Apr 20 2021 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | See Remarks | Sell | S | 27.01 | 5,890 | 159,086 | 129,119 | 135 K to 129.1 K (-4.36 %) |
| Apr 20 2021 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | See Remarks | Sell | S | 27.01 | 759 | 20,500 | 135,009 | 135.8 K to 135 K (-0.56 %) |
| Apr 02 2021 | MYGN | MYRIAD GENETICS IN ... | Santa Eric | Chief Growth Office ... | Grant | A | 0.00 | 16,420 | 0 | 16,420 | 0 to 16.4 K |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Option Exercise | M | 24.89 | 21,966 | 546,734 | 0 | |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Option Exercise | M | 19.47 | 28,000 | 545,160 | 0 | |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Option Exercise | M | 24.89 | 8,034 | 199,966 | 0 | |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Sell | S | 30.00 | 8,034 | 241,020 | 80,128 | 88.2 K to 80.1 K (-9.11 %) |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Buy | M | 24.89 | 8,034 | 199,966 | 88,162 | 80.1 K to 88.2 K (+10.03 %) |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Sell | S | 30.00 | 21,966 | 658,980 | 80,128 | 102.1 K to 80.1 K (-21.52 %) |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Buy | M | 24.89 | 21,966 | 546,734 | 102,094 | 80.1 K to 102.1 K (+27.41 %) |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Sell | S | 30.00 | 28,000 | 840,000 | 80,128 | 108.1 K to 80.1 K (-25.90 %) |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Buy | M | 19.47 | 28,000 | 545,160 | 108,128 | 80.1 K to 108.1 K (+34.94 %) |
| Mar 26 2021 | MYGN | MYRIAD GENETICS IN ... | DIAZ PAUL J | President and CEO | Grant | A | 0.00 | 159,915 | 0 | 458,869 | 299 K to 458.9 K (+53.49 %) |
| Mar 26 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Grant | A | 0.00 | 13,326 | 0 | 80,128 | 66.8 K to 80.1 K (+19.95 %) |
| Mar 26 2021 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Grant | A | 0.00 | 18,879 | 0 | 107,029 | 88.2 K to 107 K (+21.42 %) |
| Mar 26 2021 | MYGN | MYRIAD GENETICS IN ... | Parkinson Paul | EVP Strategy and In ... | Grant | A | 0.00 | 10,661 | 0 | 87,407 | 76.7 K to 87.4 K (+13.89 %) |
| Mar 26 2021 | MYGN | MYRIAD GENETICS IN ... | Haas Kevin Richard | Chief Technology Of ... | Grant | A | 0.00 | 13,326 | 0 | 55,769 | 42.4 K to 55.8 K (+31.40 %) |
| Mar 26 2021 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President, Myriad N ... | Grant | A | 0.00 | 15,441 | 0 | 157,130 | 141.7 K to 157.1 K (+10.90 %) |
| Mar 26 2021 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, Myriad O ... | Grant | A | 0.00 | 29,556 | 0 | 135,768 | 106.2 K to 135.8 K (+27.83 %) |
| Mar 26 2021 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Grant | A | 0.00 | 32,774 | 0 | 339,925 | 307.2 K to 339.9 K (+10.67 %) |
| Feb 22 2021 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 29.69 | 11,175 | 331,786 | 307,151 | 318.3 K to 307.2 K (-3.51 %) |
| Feb 22 2021 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 29.69 | 11,175 | 331,786 | 307,151 | 318.3 K to 307.2 K (-3.51 %) |
| Feb 22 2021 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 29.69 | 11,175 | 331,786 | 307,151 | 318.3 K to 307.2 K (-3.51 %) |
| Feb 22 2021 | MYGN | MYRIAD GENETICS IN ... | Ancona Margaret | SVP Enterprise Tran ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Feb 22 2021 | MYGN | MYRIAD GENETICS IN ... | Ancona Margaret | SVP Enterprise Tran ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Feb 22 2021 | MYGN | MYRIAD GENETICS IN ... | Ancona Margaret | SVP Enterprise Tran ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Feb 22 2021 | MYGN | MYRIAD GENETICS IN ... | Haas Kevin Richard | SVP Technology | Grant | A | 0.00 | 10,000 | 0 | 42,443 | 32.4 K to 42.4 K (+30.82 %) |
| Feb 22 2021 | MYGN | MYRIAD GENETICS IN ... | Haas Kevin Richard | SVP Technology | Grant | A | 0.00 | 10,000 | 0 | 42,443 | 32.4 K to 42.4 K (+30.82 %) |
| Jan 11 2021 | MYGN | MYRIAD GENETICS IN ... | Parkinson Paul | EVP Strategy and In ... | Sell | S | 25.00 | 11,824 | 295,600 | 76,746 | 88.6 K to 76.7 K (-13.35 %) |
| Dec 07 2020 | MYGN | MYRIAD GENETICS IN ... | SPIEGELMAN DANIEL K | Director | Grant | A | 0.00 | 15,889 | 0 | 36,451 | 20.6 K to 36.5 K (+77.27 %) |
| Dec 07 2020 | MYGN | MYRIAD GENETICS IN ... | Newcomer Lee Nisley | Director | Grant | A | 0.00 | 15,889 | 0 | 27,576 | 11.7 K to 27.6 K (+135.95 %) |
| Dec 07 2020 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 15,889 | 0 | 76,679 | 60.8 K to 76.7 K (+26.14 %) |
| Dec 07 2020 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Grant | A | 0.00 | 15,889 | 0 | 70,679 | 54.8 K to 70.7 K (+29.00 %) |
| Dec 07 2020 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Grant | A | 0.00 | 15,889 | 0 | 82,679 | 66.8 K to 82.7 K (+23.79 %) |
| Nov 12 2020 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Buy | P | 16.62 | 15,000 | 249,336 | 66,790 | 51.8 K to 66.8 K (+28.96 %) |
| Nov 02 2020 | MYGN | MYRIAD GENETICS IN ... | Parkinson Paul | EVP Strategy and In ... | Sell | D | 12.43 | 2,218 | 27,570 | 88,570 | 90.8 K to 88.6 K (-2.44 %) |
| Nov 02 2020 | MYGN | MYRIAD GENETICS IN ... | Parkinson Paul | EVP Strategy and In ... | Sell | D | 12.43 | 2,218 | 27,570 | 88,570 | 90.8 K to 88.6 K (-2.44 %) |
| Oct 13 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Grant | A | 0.00 | 31,258 | 0 | 141,689 | 110.4 K to 141.7 K (+28.31 %) |
| Oct 01 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 13.04 | 2,218 | 28,923 | 48,949 | 51.2 K to 48.9 K (-4.33 %) |
| Oct 01 2020 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Sell | D | 13.04 | 416 | 5,425 | 58,366 | 58.8 K to 58.4 K (-0.71 %) |
| Oct 01 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 13.04 | 725 | 9,454 | 110,431 | 111.2 K to 110.4 K (-0.65 %) |
| Oct 01 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Sell | D | 13.04 | 6,653 | 86,755 | 169,040 | 175.7 K to 169 K (-3.79 %) |
| Oct 01 2020 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 13.04 | 5,544 | 72,294 | 207,379 | 212.9 K to 207.4 K (-2.60 %) |
| Oct 01 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 13.04 | 6,653 | 86,755 | 273,372 | 280 K to 273.4 K (-2.38 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 12.44 | 2,218 | 27,592 | 51,167 | 53.4 K to 51.2 K (-4.15 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 12.44 | 1,664 | 20,700 | 53,385 | 55 K to 53.4 K (-3.02 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 12.44 | 2,218 | 27,592 | 55,049 | 57.3 K to 55 K (-3.87 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Parkinson Paul | EVP Strategy and In ... | Sell | D | 12.44 | 3,327 | 41,388 | 69,058 | 72.4 K to 69.1 K (-4.60 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Parkinson Paul | EVP Strategy and In ... | Sell | D | 12.44 | 2,218 | 27,592 | 72,385 | 74.6 K to 72.4 K (-2.97 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Parkinson Paul | EVP Strategy and In ... | Sell | D | 12.44 | 2,218 | 27,592 | 74,603 | 76.8 K to 74.6 K (-2.89 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Sell | D | 12.44 | 2,935 | 36,511 | 58,782 | 61.7 K to 58.8 K (-4.76 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Sell | D | 12.44 | 453 | 5,635 | 61,717 | 62.2 K to 61.7 K (-0.73 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Sell | D | 12.44 | 367 | 4,565 | 62,170 | 62.5 K to 62.2 K (-0.59 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 2,935 | 36,511 | 62,592 | 65.5 K to 62.6 K (-4.48 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 2,935 | 36,511 | 62,592 | 65.5 K to 62.6 K (-4.48 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 628 | 7,812 | 65,527 | 66.2 K to 65.5 K (-0.95 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 628 | 7,812 | 65,527 | 66.2 K to 65.5 K (-0.95 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 13 | 162 | 66,155 | 66.2 K to 66.2 K (-0.02 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 13 | 162 | 66,155 | 66.2 K to 66.2 K (-0.02 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 628 | 7,812 | 66,168 | 66.8 K to 66.2 K (-0.94 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 628 | 7,812 | 66,168 | 66.8 K to 66.2 K (-0.94 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,376 | 29,557 | 111,156 | 113.5 K to 111.2 K (-2.09 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,376 | 29,557 | 111,156 | 113.5 K to 111.2 K (-2.09 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,897 | 36,039 | 113,532 | 116.4 K to 113.5 K (-2.49 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,897 | 36,039 | 113,532 | 116.4 K to 113.5 K (-2.49 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,897 | 36,039 | 116,429 | 119.3 K to 116.4 K (-2.43 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,897 | 36,039 | 116,429 | 119.3 K to 116.4 K (-2.43 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Grant | A | 0.00 | 32,800 | 0 | 119,326 | 86.5 K to 119.3 K (+37.91 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Grant | A | 0.00 | 32,800 | 0 | 119,326 | 86.5 K to 119.3 K (+37.91 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Sell | D | 12.44 | 4,546 | 56,552 | 175,693 | 180.2 K to 175.7 K (-2.52 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Sell | D | 12.44 | 5,267 | 65,521 | 180,239 | 185.5 K to 180.2 K (-2.84 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Sell | D | 12.44 | 6,653 | 82,763 | 185,506 | 192.2 K to 185.5 K (-3.46 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Grant | A | 0.00 | 41,000 | 0 | 192,159 | 151.2 K to 192.2 K (+27.12 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 12.44 | 3,627 | 45,120 | 212,923 | 216.6 K to 212.9 K (-1.67 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 12.44 | 4,214 | 52,422 | 216,550 | 220.8 K to 216.6 K (-1.91 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 12.44 | 5,544 | 68,967 | 220,764 | 226.3 K to 220.8 K (-2.45 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Grant | A | 0.00 | 32,800 | 0 | 226,308 | 193.5 K to 226.3 K (+16.95 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 12.44 | 4,546 | 56,552 | 280,025 | 284.6 K to 280 K (-1.60 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 12.44 | 6,653 | 82,763 | 284,571 | 291.2 K to 284.6 K (-2.28 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 12.44 | 5,267 | 65,521 | 291,224 | 296.5 K to 291.2 K (-1.78 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Grant | A | 0.00 | 41,000 | 0 | 296,491 | 255.5 K to 296.5 K (+16.05 %) |
| Sep 18 2020 | MYGN | MYRIAD GENETICS IN ... | Kumar Rashmi | Director | Grant | A | 0.00 | 23,923 | 0 | 23,923 | 0 to 23.9 K |
| Sep 16 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Sell | S | 13.78 | 2,804 | 38,630 | 151,159 | 154 K to 151.2 K (-1.82 %) |
| Aug 17 2020 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Grant | A | 0.00 | 6,541 | 0 | 62,537 | 56 K to 62.5 K (+11.68 %) |
| Aug 17 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Grant | A | 0.00 | 7,646 | 0 | 66,796 | 59.2 K to 66.8 K (+12.93 %) |
| Aug 17 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MWH | Grant | A | 0.00 | 11,525 | 0 | 153,963 | 142.4 K to 154 K (+8.09 %) |
| Aug 17 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Grant | A | 0.00 | 13,787 | 0 | 255,491 | 241.7 K to 255.5 K (+5.70 %) |
| Aug 14 2020 | MYGN | MYRIAD GENETICS IN ... | DIAZ PAUL J | President and CEO | Option Exercise | A | 13.38 | 342,040 | 4,576,495 | 342,040 | |
| Aug 14 2020 | MYGN | MYRIAD GENETICS IN ... | DIAZ PAUL J | President and CEO | Option Exercise | A | 13.38 | 339,088 | 4,536,997 | 339,088 | |
| Aug 14 2020 | MYGN | MYRIAD GENETICS IN ... | DIAZ PAUL J | President and CEO | Grant | A | 0.00 | 298,954 | 0 | 298,954 | 0 to 299 K |
| Jul 23 2020 | MYGN | MYRIAD GENETICS IN ... | Skovronsky Daniel | Director | Grant | A | 0.00 | 25,041 | 0 | 25,041 | 0 to 25 K |
| May 28 2020 | MYGN | MYRIAD GENETICS IN ... | SPIEGELMAN DANIEL K | Director | Grant | A | 0.00 | 20,562 | 0 | 20,562 | 0 to 20.6 K |
| Feb 20 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 244,204 | 144.2 K to 244.2 K (+69.35 %) |
| Feb 12 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | S | 19.73 | 4,354 | 85,915 | 59,150 | 63.5 K to 59.2 K (-6.86 %) |
| Feb 07 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MWH | Sell | S | 30.00 | 7,273 | 218,190 | 142,438 | 149.7 K to 142.4 K (-4.86 %) |
| Dec 27 2019 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MWH | Option Exercise | M | 15.98 | 1,307 | 20,886 | 2,693 | |
| Dec 27 2019 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MWH | Buy | M | 15.98 | 1,307 | 20,886 | 149,711 | 148.4 K to 149.7 K (+0.88 %) |
| Dec 16 2019 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | P | 25.60 | 5,860 | 149,998 | 54,150 | 48.3 K to 54.2 K (+12.14 %) |
| Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | Reitan Colleen F | Director | Grant | A | 0.00 | 11,687 | 0 | 11,687 | 0 to 11.7 K |
| Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Grant | A | 0.00 | 11,687 | 0 | 51,790 | 40.1 K to 51.8 K (+29.14 %) |
| Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Grant | A | 0.00 | 11,687 | 0 | 48,290 | 36.6 K to 48.3 K (+31.93 %) |
| Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | BEST LAWRENCE C | Director | Grant | A | 0.00 | 11,687 | 0 | 60,790 | 49.1 K to 60.8 K (+23.80 %) |
| Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | Newcomer Lee Nisley | Director | Grant | A | 0.00 | 11,687 | 0 | 11,687 | 0 to 11.7 K |
| Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 11,687 | 0 | 60,790 | 49.1 K to 60.8 K (+23.80 %) |
| Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Grant | A | 0.00 | 11,687 | 0 | 76,040 | 64.4 K to 76 K (+18.16 %) |
| Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Grant | A | 0.00 | 11,687 | 0 | 54,790 | 43.1 K to 54.8 K (+27.11 %) |
| Nov 07 2019 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | P | 23.46 | 1,750 | 41,056 | 2,050 | 300 to 2.1 K (+583.33 %) |
| Nov 07 2019 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | P | 23.46 | 5,250 | 123,167 | 64,353 | 59.1 K to 64.4 K (+8.88 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 28.63 | 5,289 | 151,424 | 144,204 | 149.5 K to 144.2 K (-3.54 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 28.63 | 6,653 | 190,475 | 149,493 | 156.1 K to 149.5 K (-4.26 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Sell | D | 28.63 | 4,958 | 141,948 | 160,636 | 165.6 K to 160.6 K (-2.99 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Sell | D | 28.63 | 6,149 | 176,046 | 165,594 | 171.7 K to 165.6 K (-3.58 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Sell | D | 28.63 | 417 | 11,939 | 55,996 | 56.4 K to 56 K (-0.74 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Sell | D | 28.63 | 416 | 11,910 | 56,413 | 56.8 K to 56.4 K (-0.73 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Sell | D | 28.63 | 2,952 | 84,516 | 142,095 | 145 K to 142.1 K (-2.04 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Sell | D | 28.63 | 2,361 | 67,595 | 145,047 | 147.4 K to 145 K (-1.60 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 28.63 | 725 | 20,757 | 79,059 | 79.8 K to 79.1 K (-0.91 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MWH | Sell | D | 28.63 | 1,830 | 52,393 | 148,404 | 150.2 K to 148.4 K (-1.22 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MWH | Sell | D | 28.63 | 6,653 | 190,475 | 150,234 | 156.9 K to 150.2 K (-4.24 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 28.63 | 5,157 | 147,645 | 183,440 | 188.6 K to 183.4 K (-2.73 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 28.63 | 5,544 | 158,725 | 188,597 | 194.1 K to 188.6 K (-2.86 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 28.63 | 591 | 16,920 | 63,504 | 64.1 K to 63.5 K (-0.92 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 28.63 | 591 | 16,920 | 64,095 | 64.7 K to 64.1 K (-0.91 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 28.63 | 18,295 | 523,786 | 522,216 | 540.5 K to 522.2 K (-3.38 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 28.63 | 8,727 | 249,854 | 540,511 | 549.2 K to 540.5 K (-1.59 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 28.63 | 3,327 | 95,252 | 148,397 | 151.7 K to 148.4 K (-2.19 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 28.63 | 3,826 | 109,538 | 151,724 | 155.6 K to 151.7 K (-2.46 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 28.63 | 3,327 | 95,252 | 148,397 | 151.7 K to 148.4 K (-2.19 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 28.63 | 3,826 | 109,538 | 151,724 | 155.6 K to 151.7 K (-2.46 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Grant | A | 0.00 | 40,000 | 0 | 64,686 | 24.7 K to 64.7 K (+162.04 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 29.93 | 628 | 18,796 | 24,686 | 25.3 K to 24.7 K (-2.48 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 29.93 | 628 | 18,796 | 25,314 | 25.9 K to 25.3 K (-2.42 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 29.93 | 13 | 389 | 25,942 | 26 K to 25.9 K (-0.05 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 29.93 | 18,295 | 547,569 | 549,238 | 567.5 K to 549.2 K (-3.22 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 29.93 | 15,800 | 472,894 | 567,533 | 583.3 K to 567.5 K (-2.71 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Grant | A | 0.00 | 142,500 | 0 | 583,333 | 440.8 K to 583.3 K (+32.33 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Sell | D | 29.93 | 4,958 | 148,393 | 171,743 | 176.7 K to 171.7 K (-2.81 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Sell | D | 29.93 | 4,339 | 129,866 | 176,701 | 181 K to 176.7 K (-2.40 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Grant | A | 0.00 | 35,000 | 0 | 181,040 | 146 K to 181 K (+23.97 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Grant | A | 0.00 | 30,000 | 0 | 147,408 | 117.4 K to 147.4 K (+25.55 %) |